BEIJING, December 28, 2023--(BUSINESS WIRE)--InnoCare Pharma (HKEX: 09969; SSE: 688428) announced today that Dr. Jasmine Cui, Co-founder, Chairwoman and CEO, will present at the 42nd Annual J.P. Morgan Healthcare Conference, at 08:30 AM, January 10, 2024, U.S. Pacific Standard Time (00:30 AM, January 11, 2023, Beijing Time), to update the Company’s latest development.

The J.P. Morgan Healthcare Conference is the most influential event for the global pharma industry and the investment community. The 42nd Conference will be held in San Francisco, the United States, on January 8-11, 2024.

Time:
January 10, 08:30 AM – 08:55 AM, PST
(January 11, 00:30 AM – 00:55 AM, Beijing Time)

Speaker:
Dr. Jasmine Cui, Co-founder, Chairwoman and CEO of InnoCare

Webcast link:
https://jpmorgan.metameetings.net/events/healthcare24/sessions/49958-innocare/webcast?gpu_only=true&kiosk=true

During the Conference, we warmly welcome to have in-depth talks with our executives.

For BD professionals, contact BD@innocarepharma.com.

For investors, contact IR@innocarepharma.com.

About InnoCare

InnoCare is a commercial stage biopharmaceutical company committed to discovering, developing, and commercializing first-in-class and/or best-in-class drugs for the treatment of cancer and autoimmune diseases with unmet medical needs in China and worldwide. InnoCare has branches in Beijing, Nanjing, Shanghai, Guangzhou, Hong Kong, and United States.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231227739688/en/

Contacts

Media
Chunhua Lu
86-10-66609879
chunhua.lu@innocarepharma.com

Investor Relations
86-10-66609999
ir@innocarepharma.com